Knockout mice in neuropsychopharmacology: Present and future

International Journal of Neuropsychopharmacology

Volumn 1, Issue 1, 1998, Pages 87-92

  Mossner R ^a   Lesch, K Peter ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Conditional knockout receptors; Gene targeting; Genetic background; Transporters

Indexed keywords

EID: 0006128197     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145798001114     Document Type: Review

References (15)

1. Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mössner R, Westphal H, Lesch KP (1998). Altered brain serotonin (5-HT) homeostasis and locomoter insensitivity to MDMA ('ecstasy') in 5-HT transporter-deficient mice. Molecular Pharmacology 53, 649-655.
2. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612.
3. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmers C, Lübbert H, Bujard H (1996). Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proceedings of the National Academy of Sciences, USA 93, 10933-10938.
4. Lee YH, Sauer B, Johnson PF, Gonzalez FJ (1997). Disruption of the c/ebpa gene in adult mouse liver. Molecular Cell Biology 17, 6014-6022.
5. Lesch KP (1998b). Serotonin transporter and psychiatric disorders: listening to the gene. Neuroscientist 4, 25-34.
6. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Müller CR, Hamer DH, Murphy DL (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1483-1487.
7. Majzoub JA, Muglia LJ (1996). Molecular medicine: knockout mice. New England Journal of Medicine 334, 904-907.
8. Banbury conference on genetic background in mice (1997). Mutant mice and neuroscience: recommendations concerning genetic background. Neuron 19, 755-759.
9. Saudou F, Amara DA, Dierich A, LeMeur M, Ramboz S, Segu L, Buhot MC, Hen R (1994). Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 265, 1875-1878.
10. Shibata S, Toyama K, Shioya H, Ito M, Hirota M, Hasegawa S, Matsumoto H, Takano H, Akiyama T, Toyoshima K, Kanamaru R, Kanegae Y, Saito I, Nakamura Y, Shiba K, Noda T (1997). Rapid colorectal adenoma formation initiated by conditional targeting of the apc gene. Science 278, 120-123.
11. St-Onge L, Furth PA, Gruss P (1996). Temporal control of the Cre recombinase in transgenic mice by a tetracycline responsive promoter. Nucleic Acids Research 24, 3875-3877.
12. Takahashi N, Miner LL, Sora I, Ujike H, Revay RS, Kostic V, Jackson-Lewis V, Przedborski S, Uhl G (1997). VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proceedings of the National Academy of Sciences, USA 94, 9938-9943.
13. Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, Dallman MF, Julius DR (1995). Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 374, 542-546.
14. Wang YM, Gainetdinov RR, Fumagalli F, Xu F, Jones S, Bock C, Miller G, Wightman RM, Caron MG (1997). Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron 19, 1285-1296.
15. Wilson MA, Tonegawa S (1997). Synaptic plasticity, place cells and spatial memory: study with second generation knockouts. Trends in Neuroscience 20, 102-106.